TOPBP1 and PML

  • Number of citations of the paper that reports this interaction (PMID 12773567)
  • 21
  • Data Source:
  • HPRD (in vivo)

TOPBP1

PML

Gene Name topoisomerase (DNA) II binding protein 1 promyelocytic leukemia
Image
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 19 interactors: ABL1 AKT1 ATM BLM BMPR2 BRIP1 CHEK1 CLSTN1 E2F1 PML POLE PPP1CC RAD9A TBC1D4 TCFL5 TICRR TOP2B UBR5 ZBTB17 101 interactors: ADH1B ANKRD2 ARID3A ARNT ATF2 ATXN1 AURKA AXIN1 BANP BCL2 BCL6 CASP8AP2 CCNT1 CDK1 CDK2 CDK6 CHFR CREBBP CSNK2A1 DAXX EGFR EIF4E ELF4 EP300 FOS GATA2 HDAC1 HDAC2 HDAC3 HHEX HIPK2 HTT KAT5 KAT6A MAPK11 MAPK14 MDM2 MED7 MXD1 MYB MYC NCOA2 NCOR1 NCOR2 NFKB1 NR3C1 NR4A1 PAWR PAXIP1 PCBD2 PIAS1 PIAS2 PIN1 PLAGL1 PLSCR1 POLR2E PPARG PSMA3 RARA RB1 RBX1 RELA RNF111 RNF125 RNF4 RPL11 RXRA SENP2 SH3GL1 SIAH2 SIN3A SIRT1 SKI SMAD3 SP1 SP100 SRF STAT3 SUMO1 SUMO2 SUMO3 SUV39H1 SYNE2 TDG TERF2IP TGFBR1 TGFBR2 TGIF1 THRA TOPBP1 TP53 TP63 TP73 TRIM24 TRIM27 TRIM69 UBE2I UBE2U UBE3A ZBTB16 ZFYVE9
Entrez ID 11073 5371
HPRD ID 09678 00023
Ensembl ID ENSG00000163781 ENSG00000140464
Uniprot IDs A0AV47 A7E2X7 Q05BV8 Q92547 P29590
PDB IDs 1WF6 2XNH 2XNK 3AL2 3AL3 3JVE 3OLC 3PD7 3UEN 3UEO 1BOR
Enriched GO Terms of Interacting Partners?
Tagcloud ?
abrogates  atr  bona  checkpoint  chk1  clamp  claspin  damaging  extensively  fide  heterotetrameric  hus1  impacting  irradiation  lac  laco  lacr  lastly  localizes  onto  orphan  portion  rad1  rad9  repeats  repressor  rhino  tethering  uv 
anthracycline  apl  approaches  appropriately  arsenic  corepressors  curable  cure  deacetylase  effectiveness  explain  explains  incorporation  minority  oncogenes  pathogenetic  plzf  progranulocytic  promoters  ra  rar  recruit  refinement  relapsed  repression  safe  timed  trioxide  vast 
Tagcloud (Difference) ?
abrogates  atr  bona  checkpoint  chk1  clamp  claspin  damaging  extensively  fide  heterotetrameric  hus1  impacting  irradiation  lac  laco  lacr  lastly  localizes  onto  orphan  portion  rad1  rad9  repeats  repressor  rhino  tethering  uv 
anthracycline  apl  approaches  appropriately  arsenic  corepressors  curable  cure  deacetylase  effectiveness  explain  explains  incorporation  minority  oncogenes  pathogenetic  plzf  progranulocytic  promoters  ra  rar  recruit  refinement  relapsed  repression  safe  timed  trioxide  vast 
Tagcloud (Intersection) ?